Cargando…
Deleted in Breast Cancer 1 as a Novel Prognostic Biomarker for Digestive System Cancers: A Meta-Analysis
Deleted in Breast Cancer 1 (DBC1/CCAR2) is a regulatory protein involved in cell survival and cancer progression. Herein, we focused on summarizing the overall prognostic value of DBC1 for digestive system cancers. Therefore, we conducted a meta-analysis based on 9 studies with 2391 patients to gene...
Autores principales: | Liu, Jingting, Meng, Chunyan, Li, Changcan, Tang, Kaifeng, Tang, Hongchao, Liao, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548013/ https://www.ncbi.nlm.nih.gov/pubmed/31205519 http://dx.doi.org/10.7150/jca.26935 |
Ejemplares similares
-
TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis
por: Meng, Chunyan, et al.
Publicado: (2018) -
Prognostic and clinicopathological importance of microRNA-140 expression in cancer patients: a meta-analysis
por: Zheng, Mengxia, et al.
Publicado: (2021) -
The role of amplified in breast cancer 1 in breast cancer: A meta-analysis
por: Hou, Jianjing, et al.
Publicado: (2020) -
Prognostic and clinicopathological significance of CD155 expression in cancer patients: a meta-analysis
por: Zhang, Dan, et al.
Publicado: (2022) -
Albumin-bilirubin grade as a prognostic factor of hepatocellular carcinoma after treatment with orthotopic liver transplantation
por: Liao, Jianhua, et al.
Publicado: (2019)